Altimmune Announces Positive Phase 2b Trial Results

tipranks.com/news/company-announcements/altimmune-announces-positive-phase-2b-trial-results

Altimmune ( ($ALT) ) has issued an update. On June 26, 2025, Altimmune announced positive topline results from its IMPACT Phase 2b trial of pemvidu...

This story appeared on tipranks.com, 2025-06-26 11:55:52.
The Entire Business World on a Single Page. Free to Use →